TITLE:
Retrospective Review of Propofol versus Etomidate during Rapid Sequence Intubation in the Emergency Department at a Tertiary Academic Center
AUTHORS:
Megan A. Rocchio, Katelyn Sylvester, Nahal Beik, Nicole M. Glasser, Paul M. Szumita
KEYWORDS:
Rapid Sequence Intubation, Etomidate, Zropofol, Safety, Efficacy
JOURNAL NAME:
Pharmacology & Pharmacy,
Vol.8 No.7,
July
17,
2017
ABSTRACT: Background: Etomidate is the standard induction agent used during rapid sequence intubation (RSI) in the emergency department (ED). Etomidate shortages require providers to utilize alternative agents. The purpose of this study is to compare the safety and procedural outcomes of propofol and etomidate for RSI in the ED. Methods: This was a retrospective chart review of adult patients in the ED who received propofol or etomidate for induction during RSI. The main endpoint was hypotension, defined as a systolic blood pressure